Research Output per year
Fingerprint Dive into the research topics where Ivana Micallef is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 48 Similar Profiles
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Stem Cell Transplantation
Medicine & Life Sciences
Multiple Myeloma
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Lymphocyte Count
Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1998 2019
Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis
Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.Research output: Contribution to journal › Article
Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma
St-Pierre, F., Broski, S., LaPlant, B. R., Ristow, K., Maurer, M. J., Macon, W. R., Habermann, T. M., Ansell, S. M., Thompson, C. A., Micallef, I., Nowakowski, G. S. & Witzig, T. E., Jan 1 2019, In : American journal of hematology.Research output: Contribution to journal › Article
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival
Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy
Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes
18
Citations
(Scopus)
Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials
Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, , Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.Research output: Contribution to journal › Article
Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
3
Citations
(Scopus)
History of autoimmune conditions and lymphoma prognosis
Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.Research output: Contribution to journal › Article
Lymphoma
Disease-Free Survival
Hodgkin Disease
B-Lymphocytes
Survival